RECRUITING

Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this 52 week prospective study is to learn whether a Diabetes Care Management Program using a continuous glucose monitor (CGM) and remotely monitoring (RPM) glucose readings can help improve glucose levels and diabetes related distress in individuals with uncontrolled type 2 diabetes. The CGM and RPM are used as an adjunct to usual care. The main questions it aims to answer are: Does use of CGM \& RPM improve A1c? Does use of CGM \& RPM improve the percent of time spent with glucose levels between 70-180 mg/dl? Does the diabetes care management program improve diabetes related distress? Participants enrolled in the study will be wearing a CGM. Participants will be able to see the glucose readings from the CGM and see how their glucose level responds to food, physical activity, medications and daily life. The diabetes primary care team will be remotely monitoring the participant's glucose data from the CGM. They will reach out to the participant to make adjustments in treatment regimen as needed. Participants will answer a "Problem Areas in Diabetes"questionnaire that asks questions about diabetes related distress.

Official Title

Establishing a Sustainable Diabetes Care Management Program Using Continuous Glucose Monitors and Remote Patient Monitoring for Underserved Populations in Safety Net Clinics

Quick Facts

Study Start:2025-03-18
Study Completion:2026-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06939413

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Sushma Reddy, MD
CONTACT
8103859699
sushreddyendo@yahoo.com
Jill Einstein, MD
CONTACT
4157223638
jeinstein@mavenproject.org

Principal Investigator

Sushma Reddy, MD
PRINCIPAL_INVESTIGATOR
Diabetes Solutions International

Study Locations (Sites)

Community Health Center of Franklin County
Greenfield, Massachusetts, 01301
United States

Collaborators and Investigators

Sponsor: Diabetes Solutions International

  • Sushma Reddy, MD, PRINCIPAL_INVESTIGATOR, Diabetes Solutions International

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-18
Study Completion Date2026-10

Study Record Updates

Study Start Date2025-03-18
Study Completion Date2026-10

Terms related to this study

Keywords Provided by Researchers

  • Uncontrolled type 2 diabetes mellitus
  • CGM
  • Remote patient monitoring

Additional Relevant MeSH Terms

  • Type 2 Diabetes Mellitus (T2DM)